Daniel Mack, 10% Owner at Evoke Pharma Inc (EVOK), sold 41 shares at $4.39 ($180) on 2025-01-28, disclosed to the SEC on 2025-01-30.
Open-market sale of $180 EVOK by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.